Table 2 Demographic and clinical data control donors
From: Complement activation at the motor end-plates in amyotrophic lateral sclerosis
Patient nr | Gender | Age | PMD (hours) |
|---|---|---|---|
1 | M | 69 | 5–6 |
2 | F | 65 | Unknown |
3 | F | 55 | 3.5–4 |
4 | M | 73 | 11 |
5 | M | 62 | 4–8 |
6 | F | 68 | 10 |
From: Complement activation at the motor end-plates in amyotrophic lateral sclerosis
Patient nr | Gender | Age | PMD (hours) |
|---|---|---|---|
1 | M | 69 | 5–6 |
2 | F | 65 | Unknown |
3 | F | 55 | 3.5–4 |
4 | M | 73 | 11 |
5 | M | 62 | 4–8 |
6 | F | 68 | 10 |
Journal of Neuroinflammation